Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.2.3.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.3.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LB.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.1.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.1.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.1.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.7.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.7.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.1.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.1.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDD.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDD.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDD.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used